Raghav R. Mattay

Raghav R. Mattay

Auto-generated profile, based on publicly available information

Raghav R. Mattay

Department of Radiology and Biomedical Imaging (R.M., L.P.S., K.N., S.H.), University of California San Francisco, San Francisco, California

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2023 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
RMRaghav R. Mattay
Raghav R. Mattay
KKKisoo Kim
Kisoo Kim
LSLubdha Shah
Lubdha Shah
BSBhavya Shah
Bhavya Shah
LSLeo Sugrue
Leo Sugrue
KNKazim H. Narsinh
Kazim H. Narsinh
SUMMARY: Interest in transcranial MR imaging–guided focused ultrasound procedures has recently grown. These incisionless procedures enable precise focal ablation of brain tissue using real-time monitoring by MR thermometry. This article will provide an updated review on clinically applicable technical underpinnings and considerations of proton resonance frequency MR thermometry, the most common clinically used MR thermometry sequence.

4 October 2018 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
RMR.R. Mattay
R.R. Mattay
KDK. Davtyan
K. Davtyan
MBM. Bilello
M. Bilello
AMA.C. Mamourian
A.C. Mamourian
BACKGROUND AND PURPOSE: Patients with multiple sclerosis routinely have MR imaging with contrast every 6–12 months to assess response to medication. Multiple recent studies provide evidence of tissue deposition of MR imaging contrast agents, questioning the long-term safety of these agents. The goal of this retrospective image-analysis study was to determine whether contrast could be reserved for only those patients who show new MS lesions on follow-up examinations. MATERIALS AND METHODS: We retrospectively reviewed brain MRIs of 138 patients. To increase our sensitivity, we used a previously described computerized image-comparison software to evaluate the stability or progression of multiple sclerosis white matter lesions in noncontrast FLAIR sequences. We correlated these findings with evidence of contrast-enhancing lesions on the enhanced T1 sequence from the same scan. RESULTS: Thirty-three scans showed an increase in white matter lesion burden. Among those 33 patients, 14 examinations also demonstrated enhancing new lesions. While we found a single example of enhancement of a pre-existing white matter lesion that appeared unchanged in size, that same examination showed an overall increase in lesion burden with enhancement of other, new lesions. Thus, we found that all patients with enhancing lesions had evidence of progression on their noncontrast imaging. CONCLUSIONS: Because all enhancing lesions were associated with new lesions on unenhanced imaging and progression was only evident in 24% of patients, in patients with relapsing-remitting MS, it is reasonable to consider reserving contrast for only those patients with evidence of progression on noncontrast MR images.

15 June 2021 in Journal of Digital Imaging
Verified
Journal Article
Closed access
PDF file
JRJeffrey D. Rudie
Jeffrey D. Rudie
JDJeffrey Duda
Jeffrey Duda
MDMichael Tran Duong
Michael Tran Duong
PCPo-Hao Chen
Po-Hao Chen
LXLong Xie
Long Xie
ARAndreas M. Rauschecker
Andreas M. Rauschecker

17 April 2023 in Interventional Neuroradiology
Verified
Journal Article
Closed access
MAMatthew Amans
Matthew Amans
RMRaghav Mattay
Raghav Mattay
NHNancy K Hills
Nancy K Hills
ESEric Smith
Eric Smith
DMDavid McCoy
David McCoy
KMKarl Meisel
Karl Meisel
Background: While many of the causes of pulsatile tinnitus (PT) are treatable with endovascular approaches, the risks of treatment must be balanced with the risks of the underlying cause and the psychological impact of symptoms on patients. While many physicians have anecdotal experience, the comorbid relationship of depression and anxiety with PT is unknown. The objectives of this study are to quantify the prevalence of depression and anxiety, and, to identify the demographic risk factors for impactful depression and anxiety in patients with PT. Methods: Subjects recruited from online PT groups filled out secure online questionnaires that included demographic questions, validated Tinnitus Functional Index (TFI) as well as PHQ-9 and GAD-7 questionnaires to assess the prevalence of concurrent depression and anxiety, respectively. Results: Sample included 515 surveys (84% female, 65% unemployed, mean(sd) age = 46.4 years (14.2)). Median symptom duration was 1.9 years. Data showed 46% and 37% of patients with moderate to severe depression and anxiety, respectively. Higher TFI scores were associated with moderate to severe depression (OR 1.07; 95% CI 1.06–1.09, p < 0.001) and anxiety (OR 1.05, 95% CI 1.04–1.06, p < 0.001), with TFI subscores also independently being associated in a univariate analysis. Conclusions: The prevalence of moderate to severe depression and anxiety in the PT population, which was previously unknown, is estimated in our study to be 46% and 37%, respectively. Significant association of TFI score with increased depression and anxiety scales adds further evidence of the impact of PT on the psychological health of these patients.

21 November 2024 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
BSBhavya R. Shah
Bhavya R. Shah
JTJody Tanabe
Jody Tanabe
JJJohn E. Jordan
John E. Jordan
DKDrew Kern
Drew Kern
SHStephen C. Harward
Stephen C. Harward
TKTimothy J. Kaufmann
Timothy J. Kaufmann
SUMMARY: Transcranial focused ultrasound (FUS) is a versatile, MR-guided, incisionless intervention with diagnostic and therapeutic applications for neurologic and psychiatric diseases. It is currently FDA-approved as a thermoablative treatment of essential tremor and Parkinson disease. However, other applications of FUS including BBB opening for diagnostic and therapeutic applications, sonodynamic therapy, histotripsy, and low-intensity focused ultrasound neuromodulation are all in clinical trials. While FUS targeting for essential tremor and Parkinson disease has classically relied on an indirect, landmark-based approach, development of novel, advanced MR imaging techniques such as DTI tractography and fast gray matter acquisition T1 inversion recovery has the potential to improve individualized targeting and thus potentially enhance treatment response, decrease treatment times, and avoid adverse effects. As the technology advances and the number of clinical applications increases, the role of the neuroradiologist on a multidisciplinary team will be essential in pairing advanced structural and functional imaging to further this image-guided procedure via a precision medicine approach. This multi-institutional report, written by an experienced team of neuroradiologists, neurosurgeons, and neurologists, summarizes current practices, the use of advanced imaging techniques for transcranial MR-guided high-intensity FUS, recommendations for clinical implementation, and emerging clinical indications.

5 January 2021 in CVIR Endovascular
Verified
Journal Article
Open access
PDF file
RMRaghav R. Mattay
Raghav R. Mattay
RSRichard Shlansky-Goldberg
Richard Shlansky-Goldberg
BPBryan A. Pukenas
Bryan A. Pukenas
Background: Although not standard of care, Cystic Fibrosis patients with recurrent hemoptysis occasionally have coil embolization of bronchial arteries. In the event of recanalization of these arteries in this specific subset of patients, the presence of indwelling coils makes the prospect of conventional particle embolization more difficult, preventing both adequate catheterization of the coiled segment and reflux of the particles. Case presentation: In this report, we describe a case of bronchial artery embolization of a complex Cystic Fibrosis patient with massive hemoptysis from recanalized coiled bronchial arteries utilizing a Scepter Balloon Catheter® (Microvention Terumo, USA) in administration of the liquid embolic agent Onyx® (Medtronic, USA). Conclusions: The Scepter occlusion balloon catheter allowed for careful placement of the tip within the interstices of the pre-existing coils, allowing for Onyx injection directly into the coil mass without reflux, reconfirming the benefits of Onyx embolization in bronchial artery embolization and providing evidence that the Scepter occlusion balloon catheter should be added to the armamentarium of devices used in complex bronchial artery embolization for Cystic Fibrosis patients with massive hemoptysis.